Cited by 495Bacterial Cancer TherapyNanoparticle-Based Drug DeliveryGut microbiota and health

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

Zheng, Di-Wei, Dong, Xue, Pan, Pei, Chen, Ke-Wei, Fan, Jin-Xuan, Cheng, Si-Xue, Zhang, Xian-Zheng·2019·Nature Biomedical Engineering

DOI 10.1038/s41551-019-0423-2

Open this paper in CoChat — free account

Abstract

The microbiota in the human gut is strongly correlated with the progression of colorectal cancer (CRC) and with therapeutic responses to CRC. Here, by leveraging the higher concentration of the pro-tumoural Fusobacterium nucleatum and the absence of antineoplastic butyrate-producing bacteria in the faecal microbiota of patients with CRC, we show that-in mice with orthotopic colorectal tumours or with spontaneously formed colorectal tumours-oral or intravenous administration of irinotecan-loaded dextran nanoparticles covalently linked to azide-modified phages that inhibit the growth of F. nucleatum significantly augments the efficiency of first-line chemotherapy treatments of CRC. We also show that oral administration of the phage-guided irinotecan-loaded nanoparticles in piglets led to negligible changes in haemocyte counts, immunoglobulin and histamine levels, and liver and renal functions. Phage-guided nanotechnology for the modulation of the gut microbiota might inspire new approaches for the treatment of CRC.

Integrity signals

Registry

Crossref · 10.1038/s41551-019-0423-2

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368
Intestinal inflammation targets cancer-inducing activity of the microbiota
Arthur, J. C., Perez-Chanona, E., Mühlbauer, M., Tomkovich, S., Uronis, J. M., Fan, T.-J., Campbell, B. J., Abujamel, T., Dogan, B., Rogers, A. B., et al. (2012) · Science · doi:10.1126/science.1224820 · Cited by 2,263

Show all 37 references

Sorted by citations

Items 101–200 of 495

Engineering Clinically Relevant Probiotics with Switchable “Nano‐Promoter” and “Nano‐Effector” for Precision Tumor Therapy
Cao, F., Jin, L., Zhang, C., Gao, Y., Qian, Z., Wen, H., Yang, S., Ye, Z., Hong, L., Huang, Y., et al. (2023) · Advanced Materials · doi:10.1002/adma.202304257 · Cited by 61
Antibody Engineered Platelets Attracted by Bacteria‐Induced Tumor‐Specific Blood Coagulation for Checkpoint Inhibitor Immunotherapy
Fan, J., Liu, X., Wang, X., Niu, M., Chen, Q., Zheng, D., Wei, J., Yang, X., Zeng, X., & Zhang, X. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009744 · Cited by 61
Self-citation
Synergistic Brilliance: Engineered Bacteria and Nanomedicine Unite in Cancer Therapy
Zhou, Y., Li, Q., Wu, Y., Zhang, W., Ding, L., Ji, C., Li, P., Chen, T., Feng, L., Tang, B. Z., et al. (2024) · Advanced Materials · doi:10.1002/adma.202313953 · Cited by 59
The roles and applications of short-chain fatty acids derived from microbial fermentation of dietary fibers in human cancer
Li, Y., Huang, Y., Liang, H., Wang, W., Li, B., Liu, T., Huang, Y., Zhang, Z., Qin, Y., Zhou, X., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1243390 · Cited by 57
Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets
Dai, J.-H., Tan, X.-R., Qiao, H., & Liu, N. (2023) · Protein & Cell · doi:10.1093/procel/pwad052 · Cited by 57
Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Peng, F., Hu, M., Su, Z., Hu, L., Guo, L., & Yang, K. (2024) · Advanced Materials · doi:10.1002/adma.202405331 · Cited by 57
The tumor microbiome in cancer progression: mechanisms and therapeutic potential
Zhang, W., Xiang, Y., Ren, H., Liu, Y., Wang, Q., Ran, M., Zhou, W., Lu, T., Zheng, X., Qiao, C., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02403-w · Cited by 57
Bacterial‐Mediated Tumor Therapy: Old Treatment in a New Context
Liu, Y., Niu, L., Li, N., Wang, Y., Liu, M., Su, X., Bao, X., Yin, B., & Shen, S. (2023) · Advanced Science · doi:10.1002/advs.202205641 · Cited by 56
Programmed Nanocloak of Commensal Bacteria-Derived Nanovesicles Amplify Strong Immunoreactivity against Tumor Growth and Metastatic Progression
Zhang, J., Wan, S., Zhou, H., Du, J., Li, Y., Zhu, H., Weng, L., Ding, X., & Wang, L. (2024) · ACS Nano · doi:10.1021/acsnano.3c13194 · Cited by 56
Microbe-material hybrids for therapeutic applications
Chen, M., Xia, L., Wu, C., Wang, Z., Ding, L. S., Xie, Y., Feng, W., & Chen, Y. (2024) · Chemical Society Reviews · doi:10.1039/d3cs00655g · Cited by 56
Microbiota in cancer: current understandings and future perspectives
Yao, Y., Zhu, Y., Chen, K., Chen, J., Li, Y., Li, D., & Wei, P. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02335-3 · Cited by 56
Self-citation
Tumor microbiome metabolism: A game changer in cancer development and therapy
Zhou, X., Kandalai, S., Hossain, F., & Zheng, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933407 · Cited by 54
Knowledge gaps in immune response and immunotherapy involving nanomaterials: Databases and artificial intelligence for material design
Feng, R., Yu, F., Xu, J., & Hu, X. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120469 · Cited by 53
Bacteriophage manipulation of the microbiome associated with tumour microenvironments-can this improve cancer therapeutic response?
Kabwe, M., Dashper, S. G., Bachrach, G., & Tucci, J. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuab017 · Cited by 52
Role of the microbiome in oral cancer occurrence, progression and therapy
Li, Z., Liu, Y., & Zhang, L. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105638 · Cited by 51
The power of phages: revolutionizing cancer treatment
Islam, M. S., Fan, J., & Pan, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1290296 · Cited by 50
Self-citation
Antibiofilm activity of ultra-small gold nanoclusters against Fusobacterium nucleatum in dental plaque biofilms
Zhang, Y., Chen, R., Wang, Y., Wang, P., Pu, J., Xu, X., Chen, F., Jiang, L., Jiang, Q., & Yan, F. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01672-7 · Cited by 50
The emerging tumor microbe microenvironment: From delineation to multidisciplinary approach-based interventions
Fu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
Influence of the gut microbiota on immune cell interactions and cancer treatment
Liu, C., Fu, L., Wang, Y., & Yang, W. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05709-3 · Cited by 47
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 47
Gut microbiota targeted nanomedicine for cancer therapy: Challenges and future considerations
Rajoka, M. S. R., Mehwish, H. M., Xiong, Y., Song, X., Hussain, N., Zhu, Q., & He, Z. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.10.036 · Cited by 47
Hierarchy‐Assembled Dual Probiotics System Ameliorates Cholestatic Drug‐Induced Liver Injury via Gut‐Liver Axis Modulation
Chen, Q., Li, Q., Cao, M., Yan, J., & Zhang, X. (2022) · Advanced Science · doi:10.1002/advs.202200986 · Cited by 47
Self-citation
Emerging strategies for combating Fusobacterium nucleatum in colorectal cancer treatment: Systematic review, improvements and future challenges
Liu, H., Yu, Y., Dong, A., Elsabahy, M., Yang, Y., & Gao, H. (2023) · Exploration · doi:10.1002/exp.20230092 · Cited by 46
Role of the gut microbiota in tumorigenesis and treatment
Liu, Q., Yang, Y., Pan, M., Yang, F., Yu, Y., & Qian, Z. (2024) · Theranostics · doi:10.7150/thno.91700 · Cited by 46
Smart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics
Li, X., Gao, Y., Li, H., Majoral, J., Shi, X., & Pich, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101170 · Cited by 46
Gut Phageome—An Insight into the Role and Impact of Gut Microbiome and Their Correlation with Mammal Health and Diseases
Zhang, Y., Sharma, S., Tom, L., Liao, Y., & Wu, V. C. H. (2023) · Microorganisms · doi:10.3390/microorganisms11102454 · Cited by 45
Engineered Microorganisms for Advancing Tumor Therapy
Jia, J., Wang, X., Lin, X., & Zhao, Y. (2024) · Advanced Materials · doi:10.1002/adma.202313389 · Cited by 45
The gut microbiome can be used to predict the gastrointestinal response and efficacy of lung cancer patients undergoing chemotherapy
Zhang, M., Zhou, H., Xu, S., Liu, D., Cheng, Y., Gao, B. X., Li, X., & Chen, J. (2020) · Annals of Palliative Medicine · doi:10.21037/apm-20-2183 · Cited by 45
Construction of size-transformable supramolecular nano-platform against drug-resistant colorectal cancer caused by Fusobacterium nucleatum
Yan, X., Ma, F., Chen, Q., Gou, X., Li, X., Zhang, L., & Gao, H. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.137605 · Cited by 44
New Roles for Fusobacterium nucleatum in Cancer: Target the Bacteria, Host, or Both?
Slade, D. J. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.11.006 · Cited by 44
Bacteriophage-mediated manipulations of microbiota in gastrointestinal diseases
Haddad, L. E., Mendoza, J. F., & Jobin, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1055427 · Cited by 43
Nitroreductase-instructed supramolecular assemblies for microbiome regulation to enhance colorectal cancer treatments
Chen, J., Zhang, P., Zhao, Y., Zhao, J., Wu, X., Zhang, R., Cha, R., Yao, Q., & Gao, Y. (2022) · Science Advances · doi:10.1126/sciadv.add2789 · Cited by 43
The challenge and opportunity of gut microbiota‐targeted nanomedicine for colorectal cancer therapy
Wei, Y., Shen, F., Song, H., Zhao, R., Feng, W., Pan, Y., Li, X., Yu, H., Familiari, G., Relucenti, M., et al. (2024) · iMeta · doi:10.1002/imt2.213 · Cited by 42
Recent advances in cancer nanomedicine: From smart targeting to personalized therapeutics - pioneering a new era in precision oncology
Younas, A., Wang, S., Asad, M., Mamun, A. A., Majeed, S., Sharif, A., Zhou, Q., Liu, Y., Geng, P., Shao, C., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102660 · Cited by 42
Structural design and antimicrobial properties of polypeptides and saccharide–polypeptide conjugates
Wu, Y., Xia, G., Zhang, W., Chen, K., Bi, Y., Liu, S., Zhang, W., & Liu, R. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb01916j · Cited by 42
Self-citation
Bacteriophage-mediated modulation of microbiota for diseases treatment
Zhang, Y., Li, C., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113856 · Cited by 42
Self-citation
Microbiome and pancreatic cancer: time to think about chemotherapy
de Castilhos, J., Tillmanns, K., Blessing, J., Larano, A., Borisov, V., & Stein‐Thoeringer, C. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2374596 · Cited by 41
Versatile biomimetic nanomedicine for treating cancer and inflammation disease
Zhao, Z., Wang, D., & Li, Y. (2023) · Medical Review · doi:10.1515/mr-2022-0046 · Cited by 40
Size-tunable nanogels for cascaded release of metronidazole and chemotherapeutic agents to combat Fusobacterium nucleatum-infected colorectal cancer
Xie, S., Li, W., Liu, Y., Meng, J., Cao, W., Qiu, B., & Li, X. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.018 · Cited by 40
Targeting Fusobacterium nucleatum in colorectal cancer: therapeutic strategies and future directions
Kowsarkhizi, A. S., Yousefi, B., Rahimi, A., & Aliramezani, A. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00676-w · Cited by 39
Future trends in synthetic biology in Asia
Mao, N., Aggarwal, N., Poh, C. L., Cho, B., Kondo, A., Liu, C., Yew, W. S., & Chang, M. W. (2021) · Advanced Genetics · doi:10.1002/ggn2.10038 · Cited by 39
Engineering commensal bacteria to rewire host–microbiome interactions
Hwang, I. Y., & Chang, M. W. (2019) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2019.09.007 · Cited by 39
Advance on Engineering of Bacteriophages by Synthetic Biology
Sun, Q., Shen, L., Zhang, B., Yu, J., Wei, F. X., Sun, Y., Chen, W., & Wang, S. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s402962 · Cited by 38
Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer
Wu, Q.-L., Fang, X.-T., Wan, X.-X., Ding, Q.-Y., Zhang, Y., Ji, L., Lou, Y., & Li, X. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i14.2018 · Cited by 38
A dendritic polyamidoamine supramolecular system composed of pillar[5]arene and azobenzene for targeting drug-resistant colon cancer
Liu, H., Yang, J., Yan, X., Li, C., Elsabahy, M., Chen, L., Yang, Y., & Gao, H. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb02134f · Cited by 38
Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3
Zhang, K., Dong, Y., Li, M., Zhang, W., Ding, Y., Wang, X., Chen, D., Liu, T., Wang, B., Cao, H., et al. (2023) · Cancer Science · doi:10.1111/cas.15839 · Cited by 37
Clearing intratumoral bacteria to augment tumor-therapeutic response by engineering antimicrobial dendritic mesoporous silica nanomedicine
Chen, Q., Zhu, Y., Wang, K., Wang, X., Zhang, Y., Zhou, M., Du, J., Qu, X., Shi, Z., Zhang, Y., et al. (2023) · Nano Today · doi:10.1016/j.nantod.2023.101994 · Cited by 36
Current Advances of Nanomaterial-Based Oral Drug Delivery for Colorectal Cancer Treatment
Wang, N., Chen, L., Huang, W., Gao, Z., & Jin, M. (2024) · Nanomaterials · doi:10.3390/nano14070557 · Cited by 36
Modified montmorillonite armed probiotics with enhanced on-site mucus-depleted intestinal colonization and H2S scavenging for colitis treatment
Yang, J., Ge, S., Tan, S., Liu, H., Yang, M., Liu, W., Zhang, K., Zhang, Z., Liu, J., Shi, J., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.071 · Cited by 36
Intestinal dysbiosis and colorectal cancer
Kang, Z., Jiang, S., Fang, J., & Chen, H. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003617 · Cited by 36
Facile fabrication of soy protein isolate-functionalized nanofibers with enhanced biocompatibility and hemostatic effect on full-thickness skin injury
Ke, M., Wang, Z., Dong, Q., Chen, F., Liu, H., Huselstein, C., Wang, X., & Chen, Y. (2021) · Nanoscale · doi:10.1039/d1nr03430h · Cited by 35
Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application
Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 34
The role of intratumoral microbiome in the occurrence, proliferation, metastasis of colorectal cancer and its underlying therapeutic strategies
Liao, K., Wen, J., Liu, Z., Zhang, B., Zhang, X., Fu, Y., Zhang, W., Hu, H., Ai, K., Zhu, W., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102820 · Cited by 34
Self-citation
An RGB-emitting molecular cocktail for the detection of bacterial fingerprints
Hong, S., Zheng, D., Zhang, Q., Deng, W., Song, W., Cheng, S., Sun, Z., & Zhang, X. (2020) · Chemical Science · doi:10.1039/d0sc01704c · Cited by 34
Self-citation
Inulin-based formulations as an emerging therapeutic strategy for cancer: A comprehensive review
Ghali, E. N. H. K., Pranav, Chauhan, S. C., & Yallapu, M. M. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.129216 · Cited by 33
Omics‐Enhanced Nanomedicine for Cancer Therapy
Qi, L., Li, Z., Liu, J., & Chen, X. S. (2024) · Advanced Materials · doi:10.1002/adma.202409102 · Cited by 33
Click Reaction-Assisted Peptide Immune Checkpoint Blockade for Solid Tumor Treatment
Xiao, W., Wang, Y., An, H., Hou, D., Mamuti, M., Wang, M., Wang, J., Xu, W., Hu, L., & Wang, H. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10166 · Cited by 33
Dynamic impact of virome on colitis and colorectal cancer: Immunity, inflammation, prevention and treatment
Wang, Z., Guo, K., Liu, Y., Huang, C., & Wu, M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.10.004 · Cited by 33
Dysbiosis and colorectal cancer: conducive factors, biological and molecular role, and therapeutic prospectives
Singh, G., Chaudhry, Z., Boyadzhyan, A., Sasaninia, K., & Rai, V. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002329 · Cited by 32
Lytic Bacteriophage EFA1 Modulates HCT116 Colon Cancer Cell Growth and Upregulates ROS Production in an Enterococcus faecalis Co-culture System
Kabwe, M., Meehan-Andrews, T., Ku, H., Petrovski, S., Batinovic, S., Chan, H. T., & Tucci, J. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.650849 · Cited by 32
The Gut Microbiota of Healthy and Flavobacterium psychrophilum-Infected Rainbow Trout Fry Is Shaped by Antibiotics and Phage Therapies
Donati, V. L., Madsen, L., Middelboe, M., Strube, M. L., & Dalsgaard, I. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.771296 · Cited by 31
Decoding the microbiome: advances in genetic manipulation for gut bacteria
Chen, Z., Jin, W., Hoover, A., Chao, Y., & Ma, Y. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.05.007 · Cited by 31
Three‐in‐One Peptide Prodrug with Targeting, Assembly and Release Properties for Overcoming Bacterium‐Induced Drug Resistance and Potentiating Anti‐Cancer Immune Response
Gao, G., Jiang, Y., Chen, J., Xu, X., Sun, X., Xu, H., Liang, G., Liu, X., Zhan, W., Wang, M., et al. (2024) · Advanced Materials · doi:10.1002/adma.202312153 · Cited by 30
Spatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance
Tan, Q., Cao, X., Zou, F., Wang, H., Xiong, L., & Deng, S. (2025) · Biomedicines · doi:10.3390/biomedicines13051261 · Cited by 30
Single-atom doping in carbon black nanomaterials for photothermal antibacterial applications
Yang, Y., Sun, J., Wen, J., Mo, S., Wang, J., Zhang, Z., Wang, G., Liu, M., & Liu, H. (2021) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2021.100535 · Cited by 30
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response
Zhao, T., Wang, X., Fu, L., & Yang, K. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.144 · Cited by 30
A Microbial Community Cultured in Gradient Hydrogel for Investigating Gut Microbiome‐Drug Interaction and Guiding Therapeutic Decisions
Zheng, D., Qiao, J., Ma, J., An, J., Yang, C., Zhang, Y., Cheng, Q., Rao, Z., Zeng, S., Wang, L., et al. (2023) · Advanced Materials · doi:10.1002/adma.202300977 · Cited by 30
Self-citation
The efficacy of prevention for colon cancer based on the microbiota therapy and the antitumor mechanisms with intervention of dietary Lactobacillus
Xu, F., Li, Q., Wang, S., Dong, M., Xiao, G., Bai, J., Wang, J., & Sun, X. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00189-23 · Cited by 30
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
Chen, C., Beloqui, A., & Xu, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115117 · Cited by 30
Developing functional hydrogels for treatment of oral diseases
Song, C., Liu, R., Fang, Y., Gu, H., & Wang, Y. (2024) · Smart Medicine · doi:10.1002/smmd.20240020 · Cited by 29
Neutrophil‐Mimicking Nanomedicine Eliminates Tumor Intracellular Bacteria and Enhances Chemotherapy on Liver Metastasis of Colorectal Cancer
Niu, Y., Zhao, X., Li, Y., Ma, X., Yang, W., Ma, J., Li, W., & Yuan, W. (2025) · Advanced Science · doi:10.1002/advs.202504188 · Cited by 29
Phage therapy in noncommunicable diseases
Kviatcovsky, D., Valdés‐Mas, R., Federici, S., & Elinav, E. (2023) · Science · doi:10.1126/science.adh2718 · Cited by 29
Fabrication of hyaluronic acid-inulin coated Enterococcus faecium for colon-targeted delivery to fight Fusobacterium nucleatum
Zhu, P., Meng, L., Shu, Y., Xu, Y., Liu, W., Bi, Y., Xu, J., Meng, L., & Li, Y. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.121797 · Cited by 28
Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling
Wang, L., Jiang, W., Yang, M., Danzeng, Q., Liu, S., & Cui, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02275-z · Cited by 28
Phage therapy as a revitalized weapon for treating clinical diseases
Wang, Y., & Yu, Y. (2025) · Microbiome Research Reports · doi:10.20517/mrr.2025.31 · Cited by 28
Current Status of Phage Therapy against Infectious Diseases and Potential Application beyond Infectious Diseases
Xu, H., Xu, W., & Zhang, L. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/4913146 · Cited by 28
Convergence of Nanotechnology and Bacteriotherapy for Biomedical Applications
Liu, J., Yuan, S., Bremmer, A., & Hu, Q. (2024) · Advanced Science · doi:10.1002/advs.202309295 · Cited by 27
Advances and optimization strategies in bacteriophage therapy for treating inflammatory bowel disease
Yang, L., Li, X.-M., Duan, H.-Y., Yang, K., & Ye, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1398652 · Cited by 27
The Human Gut Virome and Its Relationship with Nontransmissible Chronic Diseases
Ezzatpour, S., Mondragón, A. D. C., Cardelle‐Cobas, A., Lamas, A., López-Santamarina, A., Miranda, J. M., & Aguilar, H. C. (2023) · Nutrients · doi:10.3390/nu15040977 · Cited by 27
The role of microbiota in the development and treatment of gastric cancer
Wang, Y., Han, W., Wang, N., Han, M., Ban, M., Dai, J., Dong, Y., Sun, T., & Xu, J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1224669 · Cited by 27
Multifunctional nanodrug for simultaneously combating chemoresistance and immunosuppression in Fusobacterium nucleatum-associated colorectal cancer
Li, X., Wu, M., Wu, Y. C., Xin, Y., Gao, L., Elsabahy, M., Wang, X., Zhang, J., Qu, X., & Gao, H. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.02.013 · Cited by 26
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma
Yao, J., Ning, B., & Ding, J. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2473504 · Cited by 26
The gut virome in association with the bacteriome in gastrointestinal diseases and beyond: roles, mechanisms, and clinical applications
Feng, Z., Burgermeister, E., Philips, A., Zuo, T., & Wen, W. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf010 · Cited by 26
Engineered Live Biotherapeutics: Progress and Challenges
Tan, Y., Shen, J., Si, T., Ho, C. L., Li, Y., & Dai, L. (2020) · Biotechnology Journal · doi:10.1002/biot.202000155 · Cited by 26
Harnessing stepping-stone hosts to engineer, select, and reboot synthetic bacteriophages in one pot
Li, C., Deng, Z., Tao, H., Song, W., Xing, B., Liu, W., Kong, L., Yuan, S., Ma, Y., Wu, Y., et al. (2022) · Cell Reports Methods · doi:10.1016/j.crmeth.2022.100217 · Cited by 26
Updated design strategies for oral delivery systems: maximized bioefficacy of dietary bioactive compounds achieved by inducing proper digestive fate and sensory attributes
Xiao, J., Tian, W., Abdullah, Wang, H., Chen, M., Huang, Q., Zhang, M., Lu, M., Song, M., & Cao, Y. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2109583 · Cited by 26
Isolation and characterization of novel Fusobacterium nucleatum bacteriophages
Wang, Y., Liu, Z., Chen, Q., Yi, L., Xu, Z., Cai, M., Qin, J., Zhang, Y., Du, G., Hong, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.945315 · Cited by 23
Fusobacterium nucleatum, immune responses, and metastatic organ diversity in colorectal cancer liver metastasis
Shigematsu, Y., Saito, R., Amori, G., Kanda, H., Takahashi, Y., Takeuchi, K., Takahashi, S., & Inamura, K. (2024) · Cancer Science · doi:10.1111/cas.16315 · Cited by 25
Gene-engineered polypeptide hydrogels with on-demand oxygenation and ECM-cell interaction mimicry for diabetic wound healing
Xie, X., Gao, C., Tan, L.-F., Chen, L., Fan, J., Xiong, W. H., Cheng, K., Zhao, Y., & Лю, Б. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122984 · Cited by 25
Self-citation
A DNA Nanopatch‐Bacteriophage System Targeting Streptococcus Gallolyticus for Inflammatory Bowel Disease Treatment and Colorectal Cancer Prevention
Zhao, Y., Zhu, M., Ling, Y., Zhao, Y., Lu, X., Chu, B., He, Y., & Wang, H. (2025) · Advanced Materials · doi:10.1002/adma.202417334 · Cited by 25
Synergistic Disruption of Metabolic Homeostasis through Hyperbranched Poly(ethylene glycol) Conjugates as Nanotherapeutics to Constrain Cancer Growth
Pan, D., Zheng, X., Zhang, L., Li, X., Zhu, G., Gong, M., Kopytynski, M., Zhou, L., Yi, Y., Zhu, H., et al. (2022) · Advanced Materials · doi:10.1002/adma.202109036 · Cited by 25
”Sociobiome”: How do socioeconomic factors influence gut microbiota and enhance pathology susceptibility? - A mini-review
Nobre, J. G., & Costa, D. A. (2022) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2022.1020190 · Cited by 25
Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out
Conti, G., D’Amico, F., Fabbrini, M., Brigidi, P., Barone, M., & Turroni, S. (2022) · Genes · doi:10.3390/genes14010055 · Cited by 25
Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy
Zhang, J., Wang, P., Wang, J., Wei, X., & Wang, M. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107185 · Cited by 25
Orally delivered targeted nanotherapeutics for the treatment of colorectal cancer
Zhang, X., Song, H., Canup, B. S. B., & Xiao, B. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1748005 · Cited by 25
Self-citation
Advanced Bioinspired Multifunctional Platforms Focusing on Gut Microbiota Regulation
Li, M., Wang, L., Lin, D., Liu, Z., Wang, H., Yang, Y., Sun, C., Ye, J., & Liu, Y. (2024) · ACS Nano · doi:10.1021/acsnano.4c05013 · Cited by 24
Application of photosensitive microalgae in targeted tumor therapy
Wang, R., Wang, Z., Zhang, M., Zhong, D., & Zhou, M. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115519 · Cited by 24
Advancing Inflammatory Bowel Disease-Driven Colorectal Cancer Management: Molecular Insights and Endoscopic Breakthroughs Towards Precision Medicine
Iacucci, M., Nardone, O. M., Ditonno, I., Capobianco, I., Pugliano, C. L., Maeda, Y., Majumder, S., Zammarchi, I., Santacroce, G., & Ghosh, S. K. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.06.035 · Cited by 24
Material Engineering in Gut Microbiome and Human Health
Yang, L., Hung, L. Y., Zhu, Y., Ding, S., Margolis, K. G., & Leong, K. W. (2022) · Research · doi:10.34133/2022/9804014 · Cited by 24
MAP7D2 reduces CD8+ cytotoxic T lymphocyte infiltration through MYH9-HMGB1 axis in colorectal cancer
Wu, Q., Yue, X., Liu, H., Zhu, Y., Ke, H., Yang, X., Yin, S., Li, Z., Zhang, Y., Hu, T., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.09.001 · Cited by 24

Authors: Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z.
Affiliations: Wuhan University (CN)
Corresponding author: Zhang, Xian-Zheng
ORCID: Dong, Xue
Pan, Pei
Chen, Ke-Wei
Fan, Jin-Xuan
Cheng, Si-Xue
Zhang, Xian-Zheng
Venue: Nature Biomedical Engineering
Publisher: Springer Science and Business Media LLC
Published: 2019-07-22
Volume: 3
Issue: 9
Pages: 717-728
ISSN: 2157-846X (ISSN-L)
DOI: 10.1038/s41551-019-0423-2
OpenAlex: W2963121075
Semantic Scholar: 94cc03369015ffa0b01be1420acac9b81fce02ac
Cited by: 495
References: 37
Citations by year: 2026: 77 · 2025: 92 · 2024: 96 · 2023: 87 · 2022: 53 · 2021: 45 · 2020: 39 · 2019: 5
FWCI: 18.93
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Biomedical Engineering (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords: colorectal cancer, gut microbiota, phage therapy, Fusobacterium nucleatum, irinotecan, dextran nanoparticles, chemotherapy response, butyrate-producing bacteria, orthotopic tumor model, piglet model
MeSH terms: Gastrointestinal Microbiome, Irinotecan, Animals, Antineoplastic Agents, Bacteria, Bacteriophages, Butyrates, Colonic Neoplasms, Dextrans, Disease Models, Animal, Drug Therapy, Immunoglobulins, Male, Mice, Inbred C57BL, Colorectal Neoplasms, Fusobacterium nucleatum, Cell Line, Tumor, Cell Proliferation, Mice, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks